Loading...

Your CDMO from Drug Substance to Drug Product

  • Drug development to Commercialization services
  • For pharmaceutical and biopharmaceutical industries
  • At all stages of drug development

Drug Substance

Gain from our strong experience in API development and manufacturing.

Sterile Drug Product

Benefit from our state-of the-art facility for development and manufacturing of your injectable Drug Product.

Specialities

Discover our Specialties from GMP cosmetics to high quality Cholesterol and Vitamin D analog products.

Discover CARBOGEN AMCIS’ CDMO services

Learn how CARBOGEN AMCIS can support you through the various clinical phases to bring your new drug from bench to market.

A global presence with
0
sites
in Switzerland, UK, France, Netherlands & China
More than
3
years
of experience in clinical API development
Production from gram to several
87
kilogrammes
scale manufacturing for API production
Up to
548
liters
of capacity for API production

CARBOGEN AMCIS Secures GMP Certification After Successful ANSM Inspection for its Aseptic Drug Product Manufacturing Site

Bubendorf, Switzerland (March 24, 2025) – Switzerland-based CARBOGEN AMCIS, a leading phar-maceutical process development and Active Pharmaceutical Ingredient (API) manufacturing com-pany, is pleased to announce the successful completion of the first inspection by the French regulatory authority, ANSM (Agence nationale de sécurité du médicament et des produits de san-té), at its state-of-the-art sterile drug product manufacturing site in Saint-Beauzire, France.

CARBOGEN AMCIS Announces Leadership Transition

BUBENDORF, Switzerland (February 3, 2025) — Switzerland-based CARBOGEN AMCIS, a leading pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, has announced the departure of its current CEO, Pascal Villemagne as of March 31 and the appointment of his replacement, Stephan Fritschi.

Swissmedic Inspection Success Highlights Excellence at CARBOGEN AMCIS Vionnaz Site

BUBENDORF, Switzerland (January 13, 2025) — Switzerland-based CARBOGEN AMCIS, a leading pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, is pleased to announce the successful completion of a Swissmedic inspection of its Vionnaz facility, reaffirming the site’s compliance with high regulatory standards.

Upcoming Events

CARBOGEN AMCIS is a Contract Development and Manufacturing Organization (CDMO) committed to providing comprehensive solutions for Drug Substance and Drug Product development. With dedication, we assist pharmaceutical and biopharmaceutical companies in the successful development, manufacturing, and market launch of their innovative drugs.

As a Pharma CDMO, we have been at the forefront of Pharmaceutical contract manufacturing for numerous years, leveraging our extensive experience to deliver high-quality services and support to our valued clients.

×

Thank you for your interest!

Before you download can we get some information?
* I agree to the Terms and Conditions.